Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 12 studies | 38% ± 17% | |
oligodendrocyte | 11 studies | 32% ± 15% | |
retinal pigment epithelial cell | 5 studies | 49% ± 15% | |
platelet | 4 studies | 19% ± 5% | |
oligodendrocyte precursor cell | 4 studies | 31% ± 12% | |
epithelial cell | 3 studies | 28% ± 8% | |
GABAergic neuron | 3 studies | 27% ± 10% | |
glutamatergic neuron | 3 studies | 39% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 32% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2845.08 | 2642 / 2642 | 100% | 20.83 | 703 / 705 |
kidney | 100% | 2094.39 | 89 / 89 | 96% | 16.03 | 868 / 901 |
skin | 91% | 1914.26 | 1638 / 1809 | 89% | 12.81 | 422 / 472 |
liver | 100% | 2316.70 | 226 / 226 | 58% | 5.07 | 237 / 406 |
breast | 68% | 448.30 | 312 / 459 | 81% | 7.06 | 902 / 1118 |
bladder | 86% | 1324.67 | 18 / 21 | 62% | 6.66 | 311 / 504 |
prostate | 71% | 482.18 | 175 / 245 | 73% | 2.93 | 366 / 502 |
adrenal gland | 41% | 191.62 | 106 / 258 | 76% | 10.08 | 175 / 230 |
uterus | 82% | 531.52 | 139 / 170 | 33% | 2.35 | 152 / 459 |
esophagus | 48% | 252.93 | 700 / 1445 | 52% | 2.85 | 95 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.45 | 1 / 1 |
intestine | 55% | 327.75 | 530 / 966 | 43% | 1.74 | 224 / 527 |
blood vessel | 94% | 1014.20 | 1252 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 7.94 | 70 / 80 |
thymus | 45% | 209.65 | 294 / 653 | 21% | 1.15 | 129 / 605 |
stomach | 22% | 112.13 | 80 / 359 | 40% | 2.03 | 115 / 286 |
pancreas | 7% | 29.20 | 24 / 328 | 53% | 2.84 | 95 / 178 |
lung | 31% | 162.19 | 181 / 578 | 29% | 1.38 | 339 / 1155 |
adipose | 47% | 225.99 | 566 / 1204 | 0% | 0 | 0 / 0 |
muscle | 45% | 306.20 | 361 / 803 | 0% | 0 | 0 / 0 |
ovary | 7% | 46.54 | 13 / 180 | 31% | 1.32 | 133 / 430 |
heart | 18% | 74.02 | 152 / 861 | 0% | 0 | 0 / 0 |
spleen | 17% | 72.95 | 42 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.48 | 6 / 45 |
peripheral blood | 8% | 33.62 | 76 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030054 | Cellular component | cell junction |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | MFAP3L |
Protein name | Microfibrillar-associated protein 3-like (Testis development protein NYD-SP9) Microfibril associated protein 3 like |
Synonyms | HSD39 KIAA0626 HSD-39 |
Description | FUNCTION: May participate in the nuclear signaling of EGFR and MAPK1/ERK2. May a have a role in metastasis. . |
Accessions | D6R9L7 ENST00000506110.1 [O75121-3] ENST00000361618.4 [O75121-1] D6RGZ8 D6RDM6 ENST00000504999.1 ENST00000507601.1 ENST00000510306.1 D6RCC0 D6RCF0 ENST00000512698.1 D6RAB5 O75121 ENST00000393702.7 [O75121-3] ENST00000393704.3 [O75121-2] ENST00000502832.1 ENST00000506764.1 |